⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7147702 | 0.99 | — | — | |
| SCHEMBL7144656 | 0.73 | F2 (0.45) | — | |
| Hydrochloric Acid SCHEMBL7148146 | 0.73 | F2 (0.46) | — | |
| SCHEMBL7247787 | 0.70 | F2 (0.35) | — | |
| SCHEMBL7253220 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL7158175 | 0.69 | F2 (0.36) | — | |
| Hydrochloric Acid SCHEMBL7159952 | 0.69 | — | — | |
| SCHEMBL7359335 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL8694344 | 0.69 | CPB1 (0.32) | — | |
| SCHEMBL7101675 | 0.69 | PTGER4 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1515550-A | Thrombosis resisting preparation | — | 2004-07-28 | — | — | CN | claimed |
| EP-1361212-A1 | Peptide derivatives as antithrombotic agents | AstraZeneca AB (SE) | 2003-11-12 | — | — | EP | claimed |
| CN-1147205-A | antithrombotic agent | LILLY CO ELI (US) | 1997-04-09 | — | — | CN | claimed |
| EP-0672658-A1 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1995023609-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | claimed |